Radiation Therapy Tips for Better Patient Care and Survivorship - Health

promotion in radiation therapy at 66th ASTRO Meeting

UCLA Health Jonsson Comprehensive Cancer Center research_worker and doctor specialize in Radiation therapy are gearing up to showcase the latest in radiation oncology research and clinical test consequence at the 66th annual American Society for Radiation Oncology ( ASTRO ) meeting in Washington D.C. This significant event, keep from Sept. 29 to Oct. 2, is set to feature 23 abstraction from UCLA research_worker across assorted radiation oncology subspecialties.

Radiation Therapy Tips for Better Patient Care and Survivorship

"Our team is proud to present research that push the boundary of what's possible in radiation oncology,"state Dr. Michael Steinberg, professor and chair of Radiation Oncology at the David Geffen School of Medicine at UCLA and director of Clinical Affairs at the UCLA Health Jonsson Comprehensive Cancer Center.

One of the noteworthy presentation at ASTRO, light-emitting_diode by Dr. Joanne Weidhaas, concentrate on identify familial signature that can predict a complete response to neoadjuvant chemoradiotherapy in patient with rectal cancer. The survey, involve 90 patient, foreground the potential of a predictive model integrate microRNA-associate single nucleotide polymorphism to usher treatment decision and better patient outcomes.

research new frontier in cancer Treatment

radiation therapy, traditionally see as a local treatment for cancer, is now being reconsider as a component of a wide scheme in cancer care. Dr. Benjamin Schrank, a resident doctor in Radiation Oncology, stress the synergy between radiation therapy and other therapy, such as immunotherapy, to enhance treatment effectiveness for patient with metastatic disease.

"We're travel beyond this impression of radiation as a local therapy to the idea that radiation can cause an immune response that then can synergize with other kind of drug to dainty cancer,"

share Schrank. The combination of radiation therapy with other modality like chemotherapy can magnify the effects on cancer cell, lead to better outcomes.

In a Holocene survey show by Schrank at the ASTRO Annual Meeting, a novel antibody-drug conjugate_solution ( ADC ) target CD47 in tumor was research as a scheme to enhance immune-drive cancer treatment. This advanced approach purpose to trip immune cell to better acknowledge and extinguish cancer cell, potentially offer a new avenue for ADC design in cancer therapy.

unlock the potential of radiation Therapy

Dr. Amar Kishan, executive frailty chair of radiation oncology at UCLA, show findings on MRI-steer stereotactic body radiotherapy ( SBRT ) for prostate_gland cancer patient. The survey uncover that patient treat with MRI guidance experience fewer hanker-term side effects associate to intestine and sexual health compare to those treat with CT guidance, showcasing the benefit of advance radiation technique in better patient quality of life.

Furthermore, Dr. Ann Raldow light-emitting_diode a survey on symptom monitoring with patient-report result during definitive radiation treatment. The use of a Mobile app to report symptom show high patient satisfaction and battle, emphasizing the importance of personalize care and patient engagement in cancer treatment.

In decision, the ongoing research and promotion in radiation therapy show at the ASTRO meeting show the committedness of healthcare professional to enhance cancer treatment result and shaping the future of oncology care. Through advanced approach and interdisciplinary collaboration, the field of radiation oncology continue to evolve, offer new possibility for better patient care and survivorship.